Stereotactic body radiotherapy: current strategies and future development
about
Clinical outcomes of patients with metachronous second primary lung adenocarcinomas.Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients.
P2860
Stereotactic body radiotherapy: current strategies and future development
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Stereotactic body radiotherapy: current strategies and future development
@ast
Stereotactic body radiotherapy: current strategies and future development
@en
Stereotactic body radiotherapy: current strategies and future development
@nl
type
label
Stereotactic body radiotherapy: current strategies and future development
@ast
Stereotactic body radiotherapy: current strategies and future development
@en
Stereotactic body radiotherapy: current strategies and future development
@nl
prefLabel
Stereotactic body radiotherapy: current strategies and future development
@ast
Stereotactic body radiotherapy: current strategies and future development
@en
Stereotactic body radiotherapy: current strategies and future development
@nl
P2860
P356
P1476
Stereotactic body radiotherapy: current strategies and future development
@en
P2093
Maverick W. K. Tsang
P2860
P304
P356
10.21037/JTD.2016.03.14
P407
P433
P577
2016-07-01T00:00:00Z